The Partners Genetics Collaborative Study of Schizophrenia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00319904 |
Recruitment Status :
Completed
First Posted : April 27, 2006
Last Update Posted : October 19, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Schizophrenia |

Study Type : | Observational |
Actual Enrollment : | 451 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Partners Genetics Collaborative Study of Schizophrenia |
Study Start Date : | March 2001 |
Actual Primary Completion Date : | October 2017 |
Actual Study Completion Date : | October 2017 |

- phenotypic subtypes in relation to genetic variants [ Time Frame: Baseline ]We will collect DNA from 500 patients with schizophrenia to examine phenotypic subtypes in relation to genetic variants. Phenotypes will include subgroups based on clinical symptoms, medication response, or other biological markers including neuroimaging or pharmacologic challenges.
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Schizophrenia, any subtype Ages 18-70 years Males or females English speaking Ability to complete symptom rating scales and cognitive tests Ability to provide informed consent
Exclusion Criteria:
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00319904
United States, Massachusetts | |
Freedom Trail Clinic | |
Boston, Massachusetts, United States, 02114 |
Principal Investigator: | Daphne J Holt, M.D., PhD | Massachusetts General Hospital |
Responsible Party: | Daphne Holt, Associate Professor of Psychiatry, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00319904 |
Other Study ID Numbers: |
2001-P-000560 |
First Posted: | April 27, 2006 Key Record Dates |
Last Update Posted: | October 19, 2017 |
Last Verified: | October 2017 |
Schizophrenia DNA |
Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders |